黑料网

Objective: To determine the effectiveness of a 6 month intensive medical intervention (IMI) with caloric restriction and high-protein meal replacements versus a conventional carbohydrate-restricted (CCR) diet.

Methods: This is an observational study designed to determine weight outcomes at 6, 12, 18 and 24 months after completing the IMI or CCR treatment. Patients were also required to participate in at least 5 miles of walking and 240 minutes of overall exercise per week. The primary outcome was percent body weight loss (BWL).

Results: A total of 604 patients with obesity or overweight were studied. Sixty-seven percent were in the IMI group, versus 33% in the CCR group. Initial BMI was similar in both groups (36.4 kg/m² (SD=7.7) vs. 36.0 kg/m² (SD=7.8), p=0.608). At 6 months, the IMI group had superior body weight loss (11.9% (SD=7.4) vs. 6.0% (SD=6.1), p<0.0001). However, the IMI group had greater weight regain than the CCR group, resulting in similar weight loss at two years (7.1% (SD=10.2) vs. 8.1% (SD=6.3), p=0.735). An adjusted analysis of outcomes averaged across 2 years demonstrated 2.8% greater BWL among the IMI group. Blood pressure significantly improved in both groups (p<0.001). Males (OR=1.77, 95% CI=(1.10,2.84), p=0.019) and patients with BMI ≥ 35 kg/m² (OR=3.32, 95% CI=(1.95, 5.65), p<0.0001) were more likely to achieve weight loss success with the IMI.

Conclusion: An Intensive Medical Intervention (IMI) characterized by high-protein meal replacements and caloric restriction can be highly effective in reducing body weight, even at two years post-intervention. This type of intervention should be strongly considered among obese patients who do not qualify for bariatric surgery, those with contraindications to weight loss medications, or those in need of weight loss prior to a medical procedure.

Morbid obesity; Medical weight loss; Carbohydrate-restricted diet; Weight maintenance; Low-calorie diet; Meal replacement

Obesity is a growing public health challenge, with more than two-thirds of the adult population in the United States either overweight or obese [1]. Medical weight management with caloric restriction, supplemented with behavioral support, pharmacologic agents, and exercise, is the cornerstone of obesity treatment. Yet there is minimal scientific consensus on the optimal dietary method for losing weight and preventing weight regain [2]. Although guidelines from the American Heart Association and National Institutes of Health emphasize the importance of low-fat, high-carbohydrate diets [3], carbohydrate-restricted diets have recently garnered substantial attention in the scientific community and general public alike, and many studies have confirmed that carbohydrate restriction results in greater weight loss compared with low-fat calorie-restricted diets [1,4,5].

The therapeutic benefits of all diets, however, are limited by their efficacy, tolerability, safety, compliance, and poor third-party pay or reimbursement, among other factors [6]. A proportion of patients are unable to respond, either with inability to lose weight initially, or with significant weight regain [7]. Because medical weight loss literature is dominated by short-term, heterogeneous studies with small sample sizes, the long-term effects of these diets are often unclear [8]. Bariatric surgery has become the primary insurance-covered intervention for obesity, whereas the costs of community-based diet programs often remain a burden on the patient. These costs can be prohibitive to uninsured or under insured populations. Thus, more effective medical treatments for obesity are needed to bridge the gap between these community-based programs and bariatric surgery.

The objective of this study was to design and evaluate an intervention based on elements of the most effective weight loss programs to induce significant initial weight loss and minimize weight regain. Our observational study assesses the short and long-term outcomes of a 6 month intensive medical weight management program with caloric and carbohydrate restriction using high-protein meal replacements and behavioral therapy. Patients enrolled in a conventional carbohydrate-restricted diet served as controls. To our knowledge, no studies to date have compared similar programs. We hypothesized that our 6 month intensive medical intervention would more effectively result in short and long-term weight loss, when compared to a conventional carbohydrate-restricted diet.

This is an observational study of 604 men and women with obesity or overweight treated at an outpatient university hospital-based program. Inclusion criteria consisted of at least one visit with our medical weight loss physician (PI) and a minimum of 3 visits with either the PI or dieticians. Patients were required to have a BMI of 23 kg/m² or greater, or waist circumference greater than 35 inches for women and 40 inches for men. Patients younger than eighteen years were excluded. The university’s institutional review board approved this study.

Treatment arms

Intensive medical intervention (IMI)

Conventional carbohydrate restriction (CCR)

Data collection

Statistical methods

604 men and women with obesity or overweight were enrolled. Baseline anthropometric and clinical data are listed in Table 2. The mean age of the study population was 48 years, and 78% were female. The mean BMI was 36.3 kg/m². At intake, thirteen percent of subjects had diabetes, 30% had hypertension, and 24% had dyslipidemia; comorbidities did not differ between treatment groups (p=0.981, p=0.946, p=0.620, respectively).

The IMI group consisted of 404 (66.9%) patients and the control group consisted of 200 (33.1%) patients. The groups were similar in initial BMI (36.4 kg/m² (SD=7.7) vs. 36.0 kg/m² (SD=7.8), p=0.608). There were, however, some baseline differences between the groups. Patients in the IMI group had a lower percentage of female patients (75% vs. 84%, p=0.021), a higher percentage of White race (75% vs. 62%, p=0.0015), and were slightly older (49.0 years (SD=13.3) vs. 46.2 years (SD=14.1), p=0.017).

Ninety-five percent of enrolled patients completed 6 months of treatment. At 12, 18, and 24 months, the percentage of eligible patients who were seen at office visits for maintenance therapy and weight measurements was 52.6%, 26.8%, and 19.6%, respectively. Follow-up did not statistically differ between treatment groups (p=0.111).

Weight loss outcomes

Blood pressure

Independent predictors of successful weight loss

Adverse events

In this study, patients with obesity or overweight were placed on an intensive medical intervention or a conventional carbohydrate-restricted diet for 6 months; then, for up to two years, both patient groups were placed on a conventional carbohydrate-restricted diet thereafter. Results showed that the IMI group had superior initial body weight loss at 6 months (11.9% (SD=7.4) vs. 6% (SD=6.1), p<0.001). However, by 18 months, the IMI group had regained 3.1% of their post-intervention weight, whereas the CCR group continued to lose weight. Among those who completed 2-years of follow-up, weight loss was clinically significant in both the IMI and CCR groups, but the difference between groups was not significant (7.1% (SD=10.2) vs. 8.1% (SD=6.3), p=0.735).

The reason for similar weight loss at 2-years between the treatment groups is likely due to the 18 months of carbohydrate-restricted maintenance therapy, which was the same dietary plan for both groups. Patients who were initially on the IMI treatment and subsequently placed on CCR for maintenance therapy experienced an increase in overall caloric intake during maintenance therapy. This may be the cause of the greater weight regain in the IMI group, relative to the CCR group. Nonetheless, although the differences between the IMI and CCR groups were greatest initially and decreased over time, the differences between groups averaged across 2 years were substantial, with an adjusted 2.8% (95% CI=(1.7%,3.9%), p<0.0001) greater BWL among the IMI group.

In comparison to results from published trials on carbohydrate-restricted diets, the IMI treatment group demonstrated nearly twice the documented weight loss at 6 months (11.9% BWL (SD=7.4) vs. 6% BWL (SD=6.1), p<0.0001). As expected, the CCR arm demonstrated equivalent weight loss to similar carbohydrate-restricted dietary programs from other institutions [9,10].

When the results of our study are compared to commercially available nonmedical weight loss programs, both the IMI and CCR groups demonstrated superior weight loss results [11]. Based on the results of randomized controlled trials, participants who use nonmedical commercial weight loss programs, such as Weight Watchers and Jenny Craig, lose approximately 5% of their initial weight over 3 to 6 months, and maintain 3% BWL at 2 years [12-14]. It is important to note, however, that weight loss of this magnitude is not trivial and can be associated with reductions in obesity-related comorbidity and mortality [15].

Very low calorie diets (VLCD) provide a meaningful comparison to our study’s IMI due to similarities in program structure. VLCDs involve a complete replacement of regular meals with food or formulations that provide 400-800 calories daily, which are typically used under medical supervision, and induce rapid weight loss [6]. In a study of 40 obese patients on VLCD of 800 kcal/day, participants who had meal replacements and one conventional meal per day lost 14.1% of their initial weight at 3 months and 8.4% at one year [16]. Another multicenter study evaluated 517 individuals who entered a commercially available 26-week VLCD program. Patients who completed treatment lost 21.8% of their initial weight. Of the 43% of patients who had 1-year follow-up, mean BWL was 9.0% [17].

Based on these data, some investigators argue in favor of VLCD, noting that it induces excellent initial weight loss [18]. However, weight regain is significant, with approximately 8-9% BWL at 1 year, and only 5% at 4 years [11,19]. The IMI utilized in our study induced less initial weight loss at 6 months relative to a VLCD, but superior weight loss at one year and beyond, presumably due to increased dietary compliance with the carbohydrate-restricted maintenance therapy.

It has been suggested that rapid weight loss, when achieved in conjunction with an appropriate long-term weight management program, is successful in maintaining clinically significant weight loss over time [20]. Yet, because weight regain is a common cause of long-term failure among successfully treated patients with obesity or overweight, the choice of maintenance therapy is paramount. In this study, the choice of a carbohydrate-restricted diet as maintenance therapy was based on multiple large randomized trials demonstrating that diets moderately high in protein content improved the likelihood of weight loss maintenance [21-24]. The underlying physiology of weight loss due to carbohydrate restriction with increased protein consumption involves rebalancing the insulin-glucagon ratio in favor of lipolysis [1,6], but the long-term effectiveness of carbohydrate-restricted maintenance therapy is likely multidimensional-involving changes in thermogenesis, satiation, and sustainability, rather than a dietary shift in macronutrient composition alone.

Overall, our study demonstrated significant weight reduction at 24 months regardless of the treatment arm (IMI: 7.1%, CCR: 8.1%). However, based on our results, males and those with higher BMI achieve more weight loss under the IMI plan. Bischoff et al. also found that males fared better with their low calorie diet intervention, and speculated that males may have done better because they initially had higher BMI, and also because daily calorie restriction means more pronounced restriction for males than females [7]. Being that males have high rates of success; such intensive medical interventions may be considered as an alternative to surgical weight loss for males with higher BMI. Additionally, the IMI may be considered as a safe and effective choice for preoperative weight loss prior to bariatric surgery, or other interventions that benefit from preoperative excess weight loss, such as transplant and orthopedic surgery. The IMI may also be beneficial among patients who are resistant to induction of weight loss or unable to tolerate weight loss medications.

The significance of factors predictive of weight loss success in the CCR group, namely higher initial SBP and TSH, is less evident. An interpretation may be that patients with increased medical comorbidity may have greater motivation to lose weight and therefore succeed with a conventional carbohydrate-restricted diet.

Strengths of this study include the duration, sample size, and assessment of a novel weight management program. All body measurements were obtained by trained professionals and not through patient self-reporting. The study assessed both primary weight loss and maintenance of weight loss.

Limitations include the single center nature of the study. Patients were not prospectively randomized to treatment arms and therefore the study may be subject to more biases and confounding than a randomized controlled trial; on the other hand, it has been speculated that adherence and clinical outcomes improve when participants are able to freely select their weight-loss program, and thus randomization may underestimate the true effect of medical weight management programs [9,25,26].

Attrition rates were also significant, although the attrition rates reported in this study are similar to many other published medical weight loss studies [7,9,27], highlighting dropout and attrition as an area of much needed improvement in medical weight management. Lastly, we did not analyze our data by using a baseline-carried forward analysis because this would artificially inflate the power of our long-term data and dampen the true effect of our intervention. Certainly, a future assessment of the IMI should include randomization, improved long-term follow-up, and a full assessment of amelioration of co-morbidities with thorough laboratory assessment.

In 2013, the American Medical Association changed its classification of obesity from “a major public health problem” to a disease. One of the objectives of this change was to encourage third-party payers to increase coverage for obesity treatment. Presently, reimbursement for medical management of obesity is minimal, whereas coverage for bariatric surgery is increasing. Hopefully, as medical management continues to evolve with improved weight loss and maintenance outcomes, increases in reimbursement for medical management will follow suit.

This study demonstrates that an intensive medical intervention with caloric and carbohydrate restriction results in superior short-term weight loss versus carbohydrate restriction alone, but similar weight loss at two years. Short-term results of the IMI are comparable to medically supervised VLCD programs; however IMI weight loss is superior in the long term due to less weight regain when paired with a carbohydrate-restricted diet for weight maintenance. An intensive medical intervention program as described in this study is safe and effective, and may be used preferentially in patients who are resistant to induction of weight loss and in those who have contraindications to bariatric surgery or weight loss medications.

This study’s data analysis was funded by Robard Corporation, the manufacturer and provider of New Direction® System weight management products; the company had no impact on study design or outcomes. The authors also wish to acknowledge Corrine Cocco, Chin-Yin Schroder, and Angela Protofanousis for assistance with data collection. We also acknowledge G. Craig Wood for leading the statistical analyses cited in this publication.